Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
Summary
Sangamo’s common stock to transition trading from The Nasdaq Capital Market to OTCQB Venture Market beginning May 5, 2026
Description
Sangamo’s common stock to transition trading from The Nasdaq Capital Market to OTCQB Venture Market beginning May 5, 2026
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source